Prostatitis diagnostic study of choice
Jump to navigation
Jump to search
|
Prostatitis Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Prostatitis diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Prostatitis diagnostic study of choice |
|
Risk calculators and risk factors for Prostatitis diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2] Anum Ijaz M.B.B.S., M.D.[3]
Overview
There is no gold standard for the diagnosis and evaluation of patients presenting with prostatitis. The evaluation of a patient with acute and chronic bacterial prostatitis consists of history and physical examination and urine culture for lower urinary tract localization cultures, respectively. The evaluation of chronic pelvic pain syndrome includes tests which can be broadly divided into mandatory, recommended and optional.
Diagnostic Study of Choice
Study of choice
- There is no gold standard for the diagnosis and evaluation of patients presenting with prostatitis.[1][2] In acute prostatitis, palpation of the prostate reveals a tender and enlarged prostate.[1][3]
In chronic prostatitis, palpation of the prostate reveals a tender and soft (boggy) prostate gland.[1]
- The evaluation of a patient with acute and chronic bacterial prostatitis consists of history and physical examination and urine culture for lower urinary tract localization cultures, respectively.
- The evaluation of chronic pelvic pain syndrome includes tests which can be broadly divided into mandatory, recommended and optional.
| Acute bacterial prostatitis | Chronic bacterial prostatitis | Chronic prostatitis / chronic pelvic pain syndrome | |
| Diagnosis | Urinalysis demonstrating leukocyte esterase and/or nitrites, positive urine culture (commonly gram-negative organisms), and a digital rectal examination showing prostate tenderness and/or swelling. | Demonstration of persistent bacterial growth with comparable or identical antimicrobial susceptibility patterns on urine cultures relative to prior infections; diagnosis involve a 2-glass or 4-glass test. |
No single diagnostic test exists; diagnosis requires exclusion of infection, malignancy, urinary obstruction or retention, and neurogenic bladder through clinical history, physical examination, urine culture, and assessment of postvoid residual urine volume. |
| Evaluation |
|
Assessment of postvoid residual volume and pelvic computed tomography in immunocompromised patients or in those with ongoing pelvic discomfort despite appropriate antibiotic management. |
|
| Microbiology | Primarily gram-negative organisms | Primarily gram-negative organisms | None |
Sequence of Diagnostic Studies in Acute Bacterial Prostatitis
- A digital rectal exam (DRE) should be performed when the patient presents with fever, local pelvic/perineal pain, irritative and obstructive voiding symptoms, and other generalized symptoms of an acute infection.
- The diagnosis of acute bacterial prostatitis is confirmed by microscopic analysis of a midstream urine specimen and confirmed by culturing uropathogenic bacteriuria in a urine specimen.
- Bladder scan may be done to further rule out urinary tract obstruction.
- Patients who don’t respond to appropriate therapy may require further imaging [transrectal ultrasound (TRUS), pelvic ultrasound or computed tomography (CT) scan] to rule out prostate abscess.
Sequence of Diagnostic Studies in Chronic Bacterial Prostatitis
- A digital rectal exam (DRE) with prostatic massage should be performed when the patient presents with history of recurrent urinary tract infections and/or previous response to antibiotics
- The diagnosis of chronic bacterial prostatitis is confirmefd by the traditional Meares–Stamey 4-glass test.
- Meares–Stamey 4-glass test consists of collecting urine samples prior to the prostate massage, an initial stream urine and a midstream urine alongwith an expressed prostatic secretion (EPS) plus a post-prostatic massage urine specimen for microscopy and culture.
Source: https://jamanetwork.com/journals/jama/article-abstract/2837543]]
Sequence of Diagnostic Studies in Chronic Bacterial Prostatitis:
- Characterize pelvic pain by duration, severity, and location, and assess urinary symptoms, sexual dysfunction, chronic pain syndromes, quality of life, and functional impairment.[5]
- Screen for psychological comorbidities, as men with CP/CPPS have higher rates of depression, anxiety, and panic disorder than unaffected men.[4]
- Use validated symptom tools such as the NIH Chronic Prostatitis Symptom Index (NIH-CPSI) to assess pain, urinary symptoms, and quality of life; higher scores indicate worse symptoms, and a 6-point change is clinically meaningful.[6]
- Evaluate for alternative or coexisting conditions including urinary tract infection, urinary retention, inguinal hernia, skin or genital infections, and malignancy.[4]
- Perform physical examination of the penis, scrotum, and inguinal region for masses, bulges, erythema, edema, or tenderness, and assess areas of focal pain for signs of soft tissue infection.[4]
- Conduct digital rectal examination to assess prostate tenderness or nodularity and palpate pelvic floor musculature for tenderness.[4]
- Consider a 2-glass or 4-glass test to differentiate CP/CPPS from chronic bacterial prostatitis.[7]
- Measure postvoid residual in patients with urinary urgency, small-volume voids, or a palpable or tender bladder; abnormal findings in the setting of neurologic disease may suggest neurogenic bladder.[4]
- Obtain urine culture to rule out urinary tract infection.
- Do not perform routine PSA testing; evaluate PSA only when indicated by abnormal digital rectal examination or standard prostate cancer screening criteria, and do not attribute PSA elevation to CP/CPPS.[8]
- Perform STI testing in patients with risk factors, urethral discharge, pruritus, or dysuria.[9]
- Routine imaging is not necessary for the diagnosis of CP/CPPS.[4]
References
- ↑ 1.0 1.1 1.2 Sharp VJ, Takacs EB, Powell CR (2010). "Prostatitis: diagnosis and treatment". Am Fam Physician. 82 (4): 397–406. PMID 20704171.
- ↑ Prostatitis: Inflammation of the Prostate. NIDDK 2016. http://www.niddk.nih.gov/health-information/health-topics/urologic-disease/prostatitis-disorders-of-the-prostate/Pages/facts.aspx#sec6. Accessed on March 4, 2016
- ↑ Stevermer JJ, Easley SK (2000). "Treatment of prostatitis". Am Fam Physician. 61 (10): 3015–22, 3025–6. PMID 10839552.
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Borgert BJ, Wallen EM, Pham MN (September 2025). "Prostatitis: A Review". JAMA. 334 (11): 1003–1013. doi:10.1001/jama.2025.11499. PMID 40788632 Check
|pmid=value (help). - ↑ Clemens JQ, Brown SO, Calhoun EA (October 2008). "Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study". J Urol. 180 (4): 1378–82. doi:10.1016/j.juro.2008.06.032. PMC 2569829. PMID 18707716.
- ↑ Propert KJ, Litwin MS, Wang Y, Alexander RB, Calhoun E, Nickel JC, O'Leary MP, Pontari M, McNaughton-Collins M (March 2006). "Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)". Qual Life Res. 15 (2): 299–305. doi:10.1007/s11136-005-1317-1. PMID 16468084.
- ↑ Lai HH, Pontari MA, Argoff CE, Bresler L, Breyer BN, Chou R, Clemens JQ, De EJ, Doiron RC, Johnson D, Kirkby E, MacDonald SM, Osborne JH, Parekattil SJ, Shelly B (August 2025). "Male Chronic Pelvic Pain: AUA Guideline: Part I Evaluation and Management Approach". J Urol. 214 (2): 116–126. doi:10.1097/JU.0000000000004564. PMID 40243110 Check
|pmid=value (help). - ↑ Nadler RB, Collins MM, Propert KJ, Mikolajczyk SD, Knauss JS, Landis JR, Fowler JE, Schaeffer AJ, Alexander RB (February 2006). "Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome". Urology. 67 (2): 337–42. doi:10.1016/j.urology.2005.08.031. PMID 16442595.
- ↑ Mercer CH, Jones KG, Geary RS, Field N, Tanton C, Burkill S, Clifton S, Sonnenberg P, Mitchell KR, Gravningen K, Johnson AM (December 2018). "Association of Timing of Sexual Partnerships and Perceptions of Partners' Concurrency With Reporting of Sexually Transmitted Infection Diagnosis". JAMA Netw Open. 1 (8): e185957. doi:10.1001/jamanetworkopen.2018.5957. PMC 6324336. PMID 30646299.